Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
A Framework for Developing Pharmacotherapy for Agitation in Alzheimer's Disease: Recommendations of the ISCTM* Working Group.
Journal: The journal of prevention of Alzheimer's disease
Published: September 13, 2020
The Patient in Your Alzheimer's Disease Study May be in Another: Duplication and Deception in Clinical Trials of Alzheimer's Disease.
Journal: The journal of prevention of Alzheimer's disease
Published: February 04, 2020
Mitigating the Effects of Nonadherence in Clinical Trials.
Journal: Journal of clinical pharmacology
Published: November 02, 2015
Targeting Prodromal Alzheimer Disease With Avagacestat: A Randomized Clinical Trial.
Journal: JAMA neurology
Published: September 29, 2015
A Randomized, Double-blind, Placebo-controlled Trial of the Efficacy and Safety of Levomilnacipran ER 40-120mg/day for Prevention of Relapse in Patients with Major Depressive Disorder.
Journal: Innovations in clinical neuroscience
Published: March 22, 2014
CNS sites cooperate to detect duplicate subjects with a clinical trial subject registry.
Journal: Innovations in clinical neuroscience
Published: April 05, 2013
Safety and tolerability of the γ-secretase inhibitor avagacestat in a phase 2 study of mild to moderate Alzheimer disease.
Journal: Archives of neurology
Published: August 16, 2012
Adjunctive therapy with pregabalin in generalized anxiety disorder patients with partial response to SSRI or SNRI treatment.
Journal: International clinical psychopharmacology
Published: February 04, 2012
Failure rate and "professional subjects" in clinical trials of major depressive disorder.
Journal: The Journal of clinical psychiatry
Published: September 29, 2011
Showing 1-9 of 9
Last Updated: 09/26/2026